Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies.

Pal Chaudhary, Surendra; Reyes, Stephanie; Chase, Matthew L; Govindan, Aparna; Zhao, Lei; Luther, Jay; Bhan, Irun; Bethea, Emily; Franses, Joseph W; Paige Walsh, Elizabeth; Anne Dageford, Leigh; Kimura, Shoko; Elias, Nahel; Yeh, Heidi; Markman, James; Bozorgzadeh, Adel; Tanabe, Kenneth; Ferrone, Cristina; Zhu, Andrew X; Andersson, Karin; Thiim, Michael; Antonio Catalano, Onofrio; Kambadakone, Avinash; Vagefi, Parsia A; Qadan, Motaz; Pratt, Daniel; Hashemi, Nikroo; Corey, Kathleen E; Misdraji, Joseph; Goyal, Lipika; Clark, Jeffrey W.

Oncologist ; 28(4): 341-350, 2023 04 06.

Artigo em Inglês | MEDLINE | ID: mdl-36763374

2.

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Finn, Richard S; Qin, Shukui; Ikeda, Masafumi; Galle, Peter R; Ducreux, Michel; Kim, Tae-You; Kudo, Masatoshi; Breder, Valeriy; Merle, Philippe; Kaseb, Ahmed O; Li, Daneng; Verret, Wendy; Xu, Derek-Zhen; Hernandez, Sairy; Liu, Juan; Huang, Chen; Mulla, Sohail; Wang, Yulei; Lim, Ho Yeong; Zhu, Andrew X; Cheng, Ann-Lii.

N Engl J Med ; 382(20): 1894-1905, 2020 05 14.

Artigo em Inglês | MEDLINE | ID: mdl-32402160

3.

Biology of IDH mutant cholangiocarcinoma.

Wu, Meng-Ju; Shi, Lei; Merritt, Joshua; Zhu, Andrew X; Bardeesy, Nabeel.

Hepatology ; 75(5): 1322-1337, 2022 05.

Artigo em Inglês | MEDLINE | ID: mdl-35226770

4.

Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma.

Aoki, Shuichi; Inoue, Koetsu; Klein, Sebastian; Halvorsen, Stefan; Chen, Jiang; Matsui, Aya; Nikmaneshi, Mohammad R; Kitahara, Shuji; Hato, Tai; Chen, Xianfeng; Kawakubo, Kazumichi; Nia, Hadi T; Chen, Ivy; Schanne, Daniel H; Mamessier, Emilie; Shigeta, Kohei; Kikuchi, Hiroto; Ramjiawan, Rakesh R; Schmidt, Tyge Ce; Iwasaki, Masaaki; Yau, Thomas; Hong, Theodore S; Quaas, Alexander; Plum, Patrick S; Dima, Simona; Popescu, Irinel; Bardeesy, Nabeel; Munn, Lance L; Borad, Mitesh J; Sassi, Slim; Jain, Rakesh K; Zhu, Andrew X; Duda, Dan G.

Gut ; 71(1): 185-193, 2022 01.

Artigo em Inglês | MEDLINE | ID: mdl-33431577

5.

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.

Kelley, Robin Kate; Rimassa, Lorenza; Cheng, Ann-Lii; Kaseb, Ahmed; Qin, Shukui; Zhu, Andrew X; Chan, Stephen L; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philippe; Benzaghou, Fawzi; Banerjee, Kamalika; Hazra, Saswati; Fawcett, Jonathan; Yau, Thomas.

Lancet Oncol ; 23(8): 995-1008, 2022 08.

Artigo em Inglês | MEDLINE | ID: mdl-35798016

6.

Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma.

Cheng, Ann-Lii; Qin, Shukui; Ikeda, Masafumi; Galle, Peter R; Ducreux, Michel; Kim, Tae-You; Lim, Ho Yeong; Kudo, Masatoshi; Breder, Valeriy; Merle, Philippe; Kaseb, Ahmed O; Li, Daneng; Verret, Wendy; Ma, Ning; Nicholas, Alan; Wang, Yifan; Li, Lindong; Zhu, Andrew X; Finn, Richard S.

J Hepatol ; 76(4): 862-873, 2022 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-34902530

7.

Biliary tract cancer.

Valle, Juan W; Kelley, R Katie; Nervi, Bruno; Oh, Do-Youn; Zhu, Andrew X.

Lancet ; 397(10272): 428-444, 2021 01 30.

Artigo em Inglês | MEDLINE | ID: mdl-33516341

8.

Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2.

Finn, Richard S; Yau, Thomas; Hsu, Chih-Hung; De Toni, Enrico N; Goyal, Lipika; Galle, Peter R; Qin, ShuKui; Rao, Sujata; Sun, Fangfang; Wang, Chunxiao; Widau, Ryan C; Zhu, Andrew X.

Oncologist ; 27(12): e938-e948, 2022 12 09.

Artigo em Inglês | MEDLINE | ID: mdl-36190331

9.

Evolution of Systemic Therapy for Hepatocellular Carcinoma.

Finn, Richard S; Zhu, Andrew X.

Hepatology ; 73 Suppl 1: 150-157, 2021 01.

Artigo em Inglês | MEDLINE | ID: mdl-32380571

10.

Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.

Galle, Peter R; Finn, Richard S; Qin, Shukui; Ikeda, Masafumi; Zhu, Andrew X; Kim, Tae-You; Kudo, Masatoshi; Breder, Valeriy; Merle, Philippe; Kaseb, Ahmed; Li, Daneng; Mulla, Sohail; Verret, Wendy; Xu, Derek-Zhen; Hernandez, Sairy; Ding, Beiying; Liu, Juan; Huang, Chen; Lim, Ho Yeong; Cheng, Ann-Lii; Ducreux, Michel.

Lancet Oncol ; 22(7): 991-1001, 2021 07.

Artigo em Inglês | MEDLINE | ID: mdl-34051880

11.

Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240.

Ryoo, Baek-Yeol; Merle, Philippe; Kulkarni, Amit S; Cheng, Ann-Lii; Bouattour, Mohamed; Lim, Ho Yeong; Breder, Valeriy; Edeline, Julien; Chao, Yee; Ogasawara, Sadahisa; Yau, Thomas; Garrido, Marcelo; Chan, Stephen L; Daniele, Bruno; Norquist, Josephine M; Chen, Erluo; Siegel, Abby B; Zhu, Andrew X; Finn, Richard S; Kudo, Masatoshi.

Cancer ; 127(6): 865-874, 2021 03 15.

Artigo em Inglês | MEDLINE | ID: mdl-33231873

12.

Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab.

Zhu, Andrew X; Finn, Richard S; Kang, Yoon-Koo; Yen, Chia-Jui; Galle, Peter R; Llovet, Josep M; Assenat, Eric; Brandi, Giovanni; Motomura, Kenta; Ohno, Izumi; Daniele, Bruno; Vogel, Arndt; Yamashita, Tatsuya; Hsu, Chih-Hung; Gerken, Guido; Bilbruck, John; Hsu, Yanzhi; Liang, Kun; Widau, Ryan C; Wang, Chunxiao; Abada, Paolo; Kudo, Masatoshi.

Br J Cancer ; 124(8): 1388-1397, 2021 04.

Artigo em Inglês | MEDLINE | ID: mdl-33531690

13.

Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma.

Shigeta, Kohei; Datta, Meenal; Hato, Tai; Kitahara, Shuji; Chen, Ivy X; Matsui, Aya; Kikuchi, Hiroto; Mamessier, Emilie; Aoki, Shuichi; Ramjiawan, Rakesh R; Ochiai, Hiroki; Bardeesy, Nabeel; Huang, Peigen; Cobbold, Mark; Zhu, Andrew X; Jain, Rakesh K; Duda, Dan G.

Hepatology ; 71(4): 1247-1261, 2020 04.

Artigo em Inglês | MEDLINE | ID: mdl-31378984

14.

Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab.

Reig, Maria; Galle, Peter R; Kudo, Masatoshi; Finn, Richard; Llovet, Josep M; Metti, Andrea L; Schelman, William R; Liang, Kun; Wang, Chunxiao; Widau, Ryan C; Abada, Paolo; Zhu, Andrew X.

Liver Int ; 41(3): 598-607, 2021 03.

Artigo em Inglês | MEDLINE | ID: mdl-33188713

15.

Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology.

Galle, Peter R; Kudo, Masatoshi; Llovet, Josep M; Finn, Richard S; Karwal, Mark; Pezet, Denis; Kim, Tae-You; Yang, Tsai-Sheng; Lonardi, Sara; Tomasek, Jiri; Phelip, Jean-Marc; Touchefeu, Yann; Koh, Su-Jin; Stirnimann, Guido; Liang, Kun; Ogburn, Kenyon D; Wang, Chunxiao; Abada, Paolo; Widau, Ryan C; Zhu, Andrew X.

Liver Int ; 41(11): 2759-2767, 2021 11.

Artigo em Inglês | MEDLINE | ID: mdl-34173317

16.

Ramucirumab in patients with advanced hepatocellular carcinoma and elevated α-fetoprotein: Outcomes by treatment-emergent ascites.

Kudo, Masatoshi; Ikeda, Masafumi; Galle, Peter R; Yamashita, Tatsuya; Finn, Richard S; Liang, Kun; Wang, Chunxiao; Sakaguchi, Sachi; Abada, Paolo; Widau, Ryan C; Zhu, Andrew X.

Hepatol Res ; 51(6): 715-721, 2021 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-33743189

17.

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.

Abou-Alfa, Ghassan K; Macarulla, Teresa; Javle, Milind M; Kelley, Robin K; Lubner, Sam J; Adeva, Jorge; Cleary, James M; Catenacci, Daniel V; Borad, Mitesh J; Bridgewater, John; Harris, William P; Murphy, Adrian G; Oh, Do-Youn; Whisenant, Jonathan; Lowery, Maeve A; Goyal, Lipika; Shroff, Rachna T; El-Khoueiry, Anthony B; Fan, Bin; Wu, Bin; Chamberlain, Christina X; Jiang, Liewen; Gliser, Camelia; Pandya, Shuchi S; Valle, Juan W; Zhu, Andrew X.

Lancet Oncol ; 21(6): 796-807, 2020 06.

Artigo em Inglês | MEDLINE | ID: mdl-32416072

18.

Systemic therapies for intrahepatic cholangiocarcinoma.

Kelley, Robin Kate; Bridgewater, John; Gores, Gregory J; Zhu, Andrew X.

J Hepatol ; 72(2): 353-363, 2020 02.

Artigo em Inglês | MEDLINE | ID: mdl-31954497

19.

Is It Time to Reconsider the Milan Criteria for Selecting Patients With Hepatocellular Carcinoma for Deceased-Donor Liver Transplantation?

Costentin, Charlotte E; Bababekov, Yanik J; Zhu, Andrew X; Yeh, Heidi.

Hepatology ; 69(3): 1324-1336, 2019 03.

Artigo em Inglês | MEDLINE | ID: mdl-30229978

20.

Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.

Sirica, Alphonse E; Gores, Gregory J; Groopman, John D; Selaru, Florin M; Strazzabosco, Mario; Wei Wang, Xin; Zhu, Andrew X.

Hepatology ; 69(4): 1803-1815, 2019 04.

Artigo em Inglês | MEDLINE | ID: mdl-30251463

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: